.
MergerLinks Header Logo

New Deal


Announced

Completed

Spectris completed the acquisition of Concept Life Sciences from Equistone for $232m.

Financials

Edit Data
Transaction Value£163m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA17.53x
Share Price Premium-
One Off Charge-

Tags

Edit

testing services

contract research

Test Inspection and Certification (TIC)

United Kingdom

Private

Completed

Friendly

Private Equity

Acquisition

Single Bidder

Majority

Synopsis

Edit

Spectris, the productivity-enhancing instrumentation and controls company, completed the acquisition of Concept Life Sciences, an international scientific laboratory and consultancy business working in the life, food, and environmental sciences, from Equistone Partners, a mid-market private equity firm, for $232m. "Concept Life Sciences is a high-quality services business which further strengthens our portfolio and enhances our ability to provide customers within the pharmaceutical, life sciences and advanced materials sectors with a combined product and service proposition," John O’Higgins, Spectris CEO.

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US